Stay updated on Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Sign up to get notified when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.

Latest updates to the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.5 was added and previously v3.5.4 was removed, indicating a new site build/version. This change updates the site metadata without altering the study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision history shows Revision: v3.5.4 replacing Revision: v3.5.3, indicating a small metadata update to the entry. This does not reflect substantive changes to study details or content.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page’s software/display footer revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now lists Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to study details or page layout.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.